Jarrett S. Gorlin is CEO at Medovex Corp. (MDVX). They have made 5 open-market trades across 1 company since 2016, most recently 2017-06-19.
CIK 0001629409
5 open-market purchases totalling $343K since 2016, never a sale. Across 5 scored buys the stock is up 18.3% at ninety days, and 14.9 points ahead of the S&P over the same stretch.
5 scored purchases · one row per filing · discretionary only
| Ticker | Shares | Value |
|---|---|---|
| MDVX | 662,172 | $358K |
Shares reported on the most recent Form 4, priced at the 2017-06-20 close.
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 40% | 80% | 100% |
| Avg Move | -0.5% | +19.1% | +18.3% |
| Alpha | -0.9% | +18.5% | +14.9% |
| Scored | 5 | 5 | 5 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| MDVX | BUY | 2017-06-19 | 2017-06-20 | $0.90 | $18K | -7.7% | +4.4% | +34.1% |
| MDVX | BUY | 2017-06-06 | 2017-06-07 | $0.91 | $23K | -7.2% | -12.4% | +20.6% |
| MDVX | BUY | 2017-02-09 | 2017-02-14 | $1.04 | $140K | +8.3% | +16.7% | +8.3% |
| MDVX | BUY | 2016-04-19 | 2016-04-21 | $1.23 | $54K | +5.7% | +4.1% | +10.7% |
| MDVX | BUY | 2016-04-19 | 2016-05-13 | $1.26 | $108K | -1.4% | +82.9% | +17.9% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.